Manflu Limited - Period Ending 2022-03-31

Manflu Limited 05002370 false 2021-04-01 2022-03-31 2022-03-31 The principal activity of the company is that of a dormant company. The company was dormant throughout the year. Digita Accounts Production Advanced 6.30.9574.0 true 05002370 2021-04-01 2022-03-31 05002370 2022-03-31 05002370 core:CurrentFinancialInstruments 2022-03-31 05002370 bus:SmallEntities 2021-04-01 2022-03-31 05002370 bus:AuditExemptWithAccountantsReport 2021-04-01 2022-03-31 05002370 bus:FullAccounts 2021-04-01 2022-03-31 05002370 bus:SmallCompaniesRegimeForAccounts 2021-04-01 2022-03-31 05002370 bus:RegisteredOffice 2021-04-01 2022-03-31 05002370 bus:Director1 2021-04-01 2022-03-31 05002370 bus:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 05002370 core:KeyManagementPersonnel 2021-04-01 2022-03-31 05002370 countries:EnglandWales 2021-04-01 2022-03-31 05002370 2020-04-01 2021-03-31 05002370 2021-03-31 05002370 core:CurrentFinancialInstruments 2021-03-31 iso4217:GBP xbrli:pure

Registration number: 05002370

Manflu Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2022

Manflu Limited

Contents

Balance Sheet	1
Notes to the Unaudited Financial Statements	2

Manflu Limited

(Registration number: 05002370)
Balance Sheet as at 31 March 2022

	Note	2022 £	2021 £
Current assets
Debtors	4	200	200
Capital and reserves
Called up share capital		200	200
Shareholders' funds		200	200

For the financial year ending 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 19 July 2022

.........................................
Mr P B Davies
Director

Manflu Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2022

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 3C Enterprise Way
Airedale Business Centre
Skipton
North Yorkshire
BD23 2FJ
England

These financial statements were authorised for issue by the director on 19 July 2022.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2021 - 1).

Debtors

	2022 £	2021 £
Other debtors	200	200
	200	200

5	Related party transactions

Health and Wellbeing Brands Ltd
(Parent Company)

Dividend of £Nil (2021 - £24,950) was paid to Health and Wellbeing Brands Ltd the parent company by Manflu Ltd the subsidiary company. At the year end the balance outstanding was £200 (2021 - £200).